AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention
AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the prevention of Covid-19 in Britain. Evusheld has been approved to be used in adults who are not presently infected with (or know exposure to) the Covid-19 virus and are […]